Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis
Authors
Keywords
-
Journal
Biomed Research International
Volume 2018, Issue -, Pages 1-7
Publisher
Hindawi Limited
Online
2018-02-19
DOI
10.1155/2018/8071093
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting nuclear receptors for the treatment of fatty liver disease
- (2017) Naoki Tanaka et al. PHARMACOLOGY & THERAPEUTICS
- Effects of aspirin and enoxaparin in a rat model of liver fibrosis
- (2017) Chen-Jie Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson’s disease
- (2017) Irene Paterniti et al. PLoS One
- Genetic and clinical data reinforce the role of GAS6 and TAM receptors in liver fibrosis
- (2016) Montserrat Marí et al. JOURNAL OF HEPATOLOGY
- High-Methionine Diet Attenuates Severity of Arthritis and Modulates IGF-I Related Gene Expressions in an Adjuvant Arthritis Rats Model
- (2016) Mingxin Li et al. MEDIATORS OF INFLAMMATION
- Effect of Methionine Restriction on Bone Density and NK Cell Activity
- (2016) Mingxin Li et al. Biomed Research International
- Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis
- (2015) Colin A. Flaveny et al. CANCER CELL
- Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activation
- (2015) Mu Yongping et al. JOURNAL OF ETHNOPHARMACOLOGY
- The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis
- (2015) Kristine Griffett et al. Molecular Metabolism
- Liver X receptors in lipid metabolism: opportunities for drug discovery
- (2014) Cynthia Hong et al. NATURE REVIEWS DRUG DISCOVERY
- Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease
- (2014) Teresa Auguet et al. Biomed Research International
- MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma
- (2013) Hao Yang et al. HEPATOLOGY
- LXR activation by GW3965 alters fat tissue distribution and adipose tissue inflammation in ob/ob female mice
- (2013) Amena Archer et al. JOURNAL OF LIPID RESEARCH
- Liver X receptors agonists impede hepatitis C virus infection in an Idol-dependent manner
- (2012) Jing Zeng et al. ANTIVIRAL RESEARCH
- Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
- (2012) Kenneth Cusi GASTROENTEROLOGY
- A Role for Protein Inhibitor of Activated STAT1 (PIAS1) in Lipogenic Regulation through SUMOylation-independent Suppression of Liver X Receptors
- (2012) Yongliang Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
- (2012) Anna C. Calkin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A High-Cholesterol Diet Exacerbates Liver Fibrosis in Mice via Accumulation of Free Cholesterol in Hepatic Stellate Cells
- (2011) Toshiaki Teratani et al. GASTROENTEROLOGY
- Liver X receptors bridge hepatic lipid metabolism and inflammation
- (2011) Yuan LIU et al. Journal of Digestive Diseases
- Metabolism, LXR/LXR ligands, and tumor immune escape
- (2011) Vincenzo Russo JOURNAL OF LEUKOCYTE BIOLOGY
- Small Molecule Agonists of the Orphan Nuclear Receptors Steroidogenic Factor-1 (SF-1, NR5A1) and Liver Receptor Homologue-1 (LRH-1, NR5A2)
- (2011) Richard J. Whitby et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease
- (2011) Kouichi Miura et al. Gastroenterology Research and Practice
- Liver X Receptor Signaling Is a Determinant of Stellate Cell Activation and Susceptibility to Fibrotic Liver Disease
- (2010) Simon W. Beaven et al. GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started